Literature DB >> 32402298

Management of Gastric Adenocarcinoma for General Surgeons.

Hisakazu Hoshi1.   

Abstract

Gastric cancer is one of the most common cancers in the world, despite declining incidence of the disease in the United States. Because of the rare occurrence of the disease in the United States, there is significant treatment variance in use of diagnostic modalities, neoadjuvant/adjuvant therapies, and surgical techniques. The survival of patients with gastric cancer in the United States is significantly lower than those of Asian countries where the diagnosis is made at an earlier stage and uniform high-quality treatment is delivered. This article reviews pearls and pitfalls of multidisciplinary management of the gastric adenocarcinoma for best outcomes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnostic imaging; Endoscopy; Gastric cancer; Laparoscopy; Multimodality treatment; Neoadjuvant chemotherapy; Radiation therapy; Staging

Mesh:

Year:  2020        PMID: 32402298     DOI: 10.1016/j.suc.2020.02.004

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Construction of a Prognostic Evaluation Model for Stomach Adenocarcinoma on the Basis of Immune-Related lncRNAs.

Authors:  Chaobo Xu; Zhengwei Chen; Xiaoming Pan; Ming Liu; Guoxiong Cheng; Jiaxin Li; Yijun Mei
Journal:  Appl Biochem Biotechnol       Date:  2022-07-29       Impact factor: 3.094

2.  Folate Decorated Multifunctional Biodegradable Nanoparticles for Gastric Carcinoma Active Targeting Theranostics.

Authors:  Xin Zhang; Ronglin Yan; Ziran Wei; Dejun Yang; Zunqi Hu; Yu Zhang; Xin Huang; Hejing Huang; Weijun Wang
Journal:  Int J Nanomedicine       Date:  2022-05-31

3.  N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.

Authors:  Yibin Zhao; Xiao Yan; Yu Wang; Juan Zhou; Yang Yu
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.